The sulfide metabolite has analgesic, anti-pyretic and anti-1 To whom correspondence should be addressed inflammatory properties (5). Renal elimination of sulindac Non-steroidal anti-inflammatory drugs (NSAIDs) are occurs via its sulfone metabolite (5,7). This metabolite exhibits among the most widely prescribed drugs. In this study, no anti-inflammatory property (8). In addition to its antiwe demonstrated the efficacy of aspirin to inhibit lung inflammatory properties, sulindac is a chemopreventive agent tumorigenesis in A/J mice. Lung tumors (9.9 tumors/ that causes regression of large-bowel polyps in patients with mouse) were induced by the tobacco-specific nitrosamine, familial polyposis (9).
Introduction
Aspirin is a non-steroidal anti-inflammatory drug (NSAIDs*) extensively used for its analgesic, anti-pyretic and antirheumatic properties (1) . Retrospective and prospective epidemiological studies (reviewed in 2) concluded that regular use of aspirin reduces the risk of colorectal cancer. In a large US cohort study, participants were asked about their intake of aspirin during the month before the initial interview. The results revealed a reduced incidence of lung cancer associated with increased aspirin use (3) . In a prospective study, Thun et al. (4) observed no association between aspirin use and the risk of respiratory cancer. The debate on the effectiveness of aspirin in preventing or delaying lung cancer development needs to be explored further. Data from laboratory studies can provide rationales and incentive for investigating the efficacy of aspirin in lung cancer prevention.
Sulindac is a prodrug that is absorbed rapidly from the *Abbreviations: NSAIDs, non-steroidal anti-inflammatory drugs; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; ASA, acetylsalicylic acid; SA, salicylic acid. carcinogen in laboratory animals, such as A/J mice (26,27).
At 16 weeks after the end of the NNK treatment, the mice were fasted overnight, killed by CO 2 asphyxiation and necropsied. Lungs were fixed in Studies with microsomes prepared either from human liver Tellyesniczky's fixative for 7 days before counting the number of surface and lung tissues or from transfected human cell lines demonadenomas Ͼ1 mm. Stomachs were fixed in situ with 0.5 ml of 10% formalin, strated that NNK is a pro-carcinogen activated by cytochrome excised and stored in formalin. Papillomas Ͼ1 mm were counted. P-450 isoenzymes 1A2, 2A6, 2D6 and 2E1 (28-32). Pathways (ii) to investigate NNK metabolism in cells expressing human and gentamicin (50 µg/ml) (Sigma Chemical Co. 
Materials and methods
incubation, the cells and the media were centrifuged at 1500 g and harvested.
Chemicals
The medium was filtered with a 0.45 µm Minisart filter (Sartorius, Germany) NNK (98% purity) and [5- The medium was analyzed for NNK and NNK metabolites on a reversecylic acid (ASA) were purchased from Sigma Chemical Co. (Mississauga, phase HPLC system, using a Spherisorb ODS 2, 5 µm column 4.6ϫ250 mm Ont., Canada). Bayer non-buffered Aspirin ® and Bayer buffered Aspirin ® (Jones Chromatography Inc., Columbus, OH). Aliquots of 750 µl of the (Sterling Winthrop Inc., Ont., Canada) were purchased in a local market in filtered medium and 7 µl of the NNK metabolites standards were co-injected October 1993.
and eluted with a pH 6.0 sodium acetate buffer and methanol as described previously (34). The eluent was monitored at 254 nm and 1 ml fractions were Lung tumor assay in A/J mice collected. Aliquots of 5 ml of Scintiverse II (Fisher Scientific, Montreal, Female A/J mice (6-7 weeks old) were obtained from Jackson Laboratories Canada) were added to each fraction and radioactivity was measured. (Bar Harbor, ME). They were housed in groups of five per cage and kept Kinetic of ASA hydrolysis under standard conditions (22 Ϯ 2°C; 45 Ϯ 5% relative humidity; 12:12h light-dark cycle). They were sorted out on weight basis into six groups and Stock solution of ASA 10 mM was prepared with 9.01 mg ASA, 0.4 ml of given tap water and powdered AIN-76A diet from Harlan-Teklad (Madison, 2% NaHCO 3 and 4.6 ml of culture medium. ASA (1 mM) was added to 3 ml WI) ad libitum. Powdered NSAIDs were mixed with the diet and two feeders of cell culture media (with 1ϫ10 6 /ml or without cells). Incubations were were placed in each cage; diet consumption and spillage were monitored three performed at periods ranging from 0 min to 48 h. As described above, cells times before and after carcinogen treatment. Stock solutions of NNK were and media were then harvested. prepared in distilled water (3.49 mg/ml) and diluted in tap water. The initial Levels of ASA and SA in culture media were measured by a reverse-phase concentration of NNK was 87.4 µg/ml and was adjusted thereafter for each HPLC. The HPLC system consisted of a Waters 501 pump, Rheodyne 7125 cage according to water consumption. Water consumption was monitored injector, Waters 441 UV detector, Hewlett Packard 3390A integrator and a twice a week for 7 weeks.
C 18 µBondapak column (3.9ϫ300 mm; Waters, Milford, MA). Aliquots of Details of the treatment with NNK and the chemopreventive agents are 100 µl of the filtrate were injected and eluted with a 0.35 N acetic acid:methanol mobile phase (75:25, v/v) during a 20-min period at a flow rate of 1.2 ml/ min. The eluent was monitored at 280 nm. Retention time was 11 min for ASA and 16 min for SA. Results were calculated from the linear regression curve, which related peak areas and the given concentrations of ASA and SA. Concentrations of salicylates in culture medium were compared by a splitplot statistical analysis.
Results

Lung adenoma assay
The numbers of tumors induced by NNK with or without NSAIDs are shown in Table I . The total dose of NNK was 9.1 mg per mouse. The number of lung tumors in untreated mice was low (0.2 tumor/mouse) and comparable to previous studies (35). Treatment with NNK only induced 9.92 tumors/ mouse, but this number was reduced to 4.72 tumors/mouse (52% inhibition) in mice treated with sulindac. ASA and nonbuffered Aspirin ® reduced lung tumor multiplicity to 3.93 (60%) and 3.71 tumors/mouse (62%), respectively. In contrast, buffered Aspirin ® had negligible effects on lung tumorigenesis. Body weight gains of NNK-treated mice were 11 to 21% lower than the untreated mice (Table I) . Therefore, giving NNK in drinking water for 7 weeks delays the gain of body Discussion weight. After the end of NNK treatment, body weight gains
The incidence of lung cancer among the Canadian population resumed. Body weight gains of NNK-and NNKϩ NSAIDsreached 22% in men and 11% in women (36). Considering treated mice were not significantly different.
the low 5-year survival rate (8-12%) of lung cancer, prevention Metabolism of NNK becomes a realistic alternative. The use of NSAIDs in clinical In the presence of h1A2 v2 cells,~50% of NNK were converted trials on the chemoprevention of colorectal cancer has shown to NNAL after 48 h (data not shown). Metabolic activation of promising results, but no information on the effectiveness of NNK is initiated by α-carbon hydroxylation (Figure 2 ). The these agents against lung cancer is available. Obviously, a four end products of this activation are the metabolite numbers better understanding of the mechanism of the action of NSAIDs 10, 11, 12 and 13. These numbers refer to structures in Figure  would help in the design of chemoprevention clinical trials.
The sum of the NNK metabolites reflect the extent of the
This study is the first one to demonstrate the effectiveness total activation of NNK. The extent of NNK metabolism and of aspirin in inhibiting lung tumorigenesis in laboratory its inhibition by salicylates, sulindac and the two sulindac animals. This observation is particularly significant considering metabolites are shown in Tables II and III, respectively. Results that it has been estimated that 10-20 thousand tons of aspirin shown in Table II indicate that neither ASA nor SA (500 µM are consumed in the USA every year (1). The doses of NSAIDs or 1 mM) inhibits NNK α-carbon hydroxylation. As shown in used in this study are comparable to the maximal recommended Table III , sulindac and its sulfide and sulfone metabolites at daily doses for humans. In this study, we used non-buffered 1 mM concentrations inhibited NNK metabolism by 90, 92
Aspirin ® at a dose of 31.7 mg/kg of body weight, while and 65%, respectively. SKF 525A, a P-450 inhibitor, was used the recommended maximal anti-pyretic and anti-inflammatory as a positive control and inhibited the metabolism of NNK doses are 55.7 and 83.6 mg/kg of body weight, respectively. by 76%.
These results lead to the hypothesis that regular use of aspirin Rate of ASA hydrolysis might reduce the risk of lung cancer in smokers. Previous studies in our laboratory (19, 20) have shown that Results of the stability of ASA in the culture media over a NSAIDs other than aspirin inhibit pulmonary carcinogenesis. 48-h period, in the presence and absence of h1A2 v2 cells, These studies demonstrate that the extent of inhibition varies are shown in Figure 3 . Hydrolysis occurred linearly with time.
depending on the type of NSAID. While sulindac was After 18 h, almost all ASA had been hydrolyzed to SA. The effective against NNK-induced lung tumorigenesis, ibuprofen extent of hydrolysis of ASA to salicylates was higher with and piroxicam were less effective and naproxen had no effect. rather than without h1A2 v2 cells between 0 and 12 h (P Ͻ 0.001).
In this study, we observed 52% inhibition with the use of of NSAIDs has an impact on their chemopreventive efficacies in A/J mice. A previous study has demonstrated that α-carbon hydroxylation of NNK is catalyzed by various P-450s, including human P-450 1A2 (30). Our results confirm these observations. Human lymphoblastoid cells that express human P-450 1A2 catalyze α-carbon hydroxylation (activation pathway, Table II) but not pyridine N-oxidation (detoxification pathway) of NNK (data not shown). We observed no inhibition of NNK metabolism even at relatively high concentrations of ASA (500 µM and 1 mM) or SA (1 mM). These results correlate with other studies that show that aspirin does not affect the metabolism of NNK (38, 39) . Using rat lung microsomes, Smith et al. (38) observed a 0-9% inhibition of the NNK metabolism by aspirin at concentrations varying from 30 to 300 µM. With rat liver microsomes, Guo et al. (39) observed no inhibition of NNK metabolism with a 100 µM aspirin. We conclude that inhibition of tumorigenesis by aspirin could not Aspirin is known to be an inhibitor of prostaglandin synthesis (40) . Bilodeau et al. (41) reported that sulindac reduces plasma levels of PGE 2 by 51%, and that naproxen has no effect. sulindac. This result is comparable to the percentage inhibition Considering that PGE 2 favors clonal expansion of initiated previously reported (51 and 53%) (19, 20) . ASA and noncells, Bilodeau et al. (41) suggested that lower levels of buffered Aspirin ® reduce by 60 and 62%, respectively, the PGE 2 would delay tumor development. Further studies by our number of lung tumors (Table I ). Our results demonstrate research group are focusing on the role of the inhibition of that aspirin is as effective as sulindac in preventing lung prostaglandin synthesis, which is a crucial element in lung carcinogenesis.
cancer chemoprevention. One of the major side effects of ASA is its gastric toxicity.
In order to study the effect of ASA on NNK metabolism, Various formulations of aspirin, such as non-buffered, buffered our research group decided to dissolve ASA in a culture and enteric-coated formulations, have been developed to medium at pH 7.6. However, Thiessen (42) has reported that eliminate this problem. The absorption of ASA can be influ-ASA is quickly hydrolyzed to SA in aqueous solutions. As a enced by many factors: tablet solubility, gastric pH, rate result, we also had to determine the rate of ASA hydrolysis of disintegration and food ingestion. In a study on aspirin by h1A2 v2 cells. In the first part of the curve (from 0 to 18 pharmacokinetics in rats, Fu et al. (37) compared the bioh), we observed a difference between results with cells and availability of buffered and unbuffered ASA. The unbuffered results without cells. This difference was probably due to a formulation was found to give higher AUC (area under curve) cellular absorption of ASA. These results show that we still than the buffered formulation. Fu et al. attributed this difference had half of the initial amount of ASA after 12 h. to the shift of the absorption of the aspirin from the stomach Sulindac is an anti-inflammatory prodrug that has to be to the intestine (where the aspirin may be more hydrolyzed).
reduced to a sulfide to exhibit anti-inflammatory effectiveOur results show that while non-buffered Aspirin ® and ASA ness. Sulindac sulfone, a second metabolite, is formed by an reduce the lung tumor multiplicity, buffered Aspirin ® has no irreversible oxidation of the sulfoxide function. In this study, significant effect (Table I ). An increased gastric pH, related to we observed that sulindac and its two metabolites, at a the buffer and food absorption could have reduced or delayed aspirin absorption. Our results demonstrate that the formulation concentration of 1 mM, inhibited the metabolism of NNK in inhibited NNK metabolism (see Table III ). Because the P-450
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1A2 is the only P-450 in the h1A2 v2 cells, we can conclude 
